CervoMed CRVO
NASDAQ CRVO
$3.02 +0.09 (+3.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

CervoMed (CRVO) Accumulated Expenses (2014 - 2026)

Updated

CervoMed (CRVO) recorded Accumulated Expenses of $2.35 million in Q2 2026, down 16.1% from $2.8 million a year earlier but up 5.4% from the prior quarter.

Analysis

CervoMed (CRVO) Accumulated Expenses (2014 - 2026) Analysis & Trends

At the end of FY2025, CervoMed reported Accumulated Expenses of $3.2 million, up 35.2% from FY2024.

  • Across earlier years, Accumulated Expenses came in at $2.37 million in FY2024.
  • Quarterly Accumulated Expenses has ranged from $2.22 million in Q1 2026 to $3.25 million in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $2.22 million (Q1 2026), $3.2 million (Q4 2025) and $3.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 CervoMed 30.02 Mn 30.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.35 Mn
Mar 31, 2026 2.22 Mn
Dec 31, 2025 3.20 Mn
Sep 30, 2025 3.25 Mn
Jun 30, 2025 2.80 Mn
Dec 31, 2024 2.37 Mn
Mar 31, 2014 410,046.00
API Access

CervoMed Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CRVO&period=max&api_key=YOUR_API_KEY